Taste masking of paracetamol by hot-melt extrusion: An in vitro and in vivo evaluation

被引:134
|
作者
Maniruzzaman, Mohammed [1 ]
Boateng, Joshua S. [1 ]
Bonnefille, Marion [2 ]
Aranyos, Attila [2 ]
Mitchell, John C. [1 ]
Douroumis, Dennis [1 ]
机构
[1] Univ Greenwich, Sch Sci, London SE18 6PF, Kent, England
[2] Alpha MOS, Toulouse, France
关键词
Hot-melt extrusion; Taste masking; Electronic tongue; Solubility parameter; SOLUBILITY PARAMETERS; SOLID DISPERSIONS; ELECTRONIC TONGUE; PHARMACEUTICAL APPLICATIONS; FORMULATION DEVELOPMENT; DISINTEGRATING TABLETS; RELEASE; BITTERNESS; POLYMERS; GRANULES;
D O I
10.1016/j.ejpb.2011.10.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was the in vitro and in vivo evaluation of the masking efficiency of hot melt extruded paracetamol (PMOL) formulations. Extruded granules containing high PMOL loadings in Eudragit EPO (R) (EPO) or Kollidon (R) VA64 (VA64) were prepared by hot-melt extrusion (HME). The taste masking effect of the processed formulation was evaluated in vivo by a panel of six healthy human volunteers. In addition, in vitro evaluation was carried out by an Astree e-tongue equipped with seven sensors. Taste sensing technology demonstrated taste improvement for both polymers by correlating the data obtained for the placebo polymers and the pure APIs alone. The best masking effect was observed for VA64 at 30% PMOL loading. The e-tongue results were in good agreement with the in vivo evaluation. In vitro dissolution of the extruded granules showed rapid PMOL releases. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:433 / 442
页数:10
相关论文
共 50 条
  • [31] Pharmaceutical applications of hot-melt extrusion: Part II
    Repka, Michael A.
    Battu, Sunil Kumar
    Upadhye, Sampada B.
    Thumma, Sridhar
    Crowley, Michael M.
    Zhang, Feng
    Martin, Charles
    McGinity, James W.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2007, 33 (10) : 1043 - 1057
  • [32] Continuous Processing of Micropellets via Hot-Melt Extrusion
    Martin Spoerk
    Ioannis Koutsamanis
    Andreas Kottlan
    Christian Makert
    Michael Piller
    Manuel Rajkovaca
    Amrit Paudel
    Johannes Khinast
    AAPS PharmSciTech, 23
  • [33] Hot-melt extrusion of sugar-starch-pellets
    Yeung, Chi-Wah
    Rein, Hubert
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 493 (1-2) : 390 - 403
  • [34] Production of enteric capsules by means of hot-melt extrusion
    Mehuys, E
    Remon, JP
    Vervaet, C
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 24 (2-3) : 207 - 212
  • [35] Hot-melt extrusion - basic principles and pharmaceutical applications
    Lang, Bo
    McGinity, James W.
    Williams, Robert O., III
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2014, 40 (09) : 1133 - 1155
  • [36] Hot-melt extrusion for enhanced delivery of drug particles
    Miller, Dave A.
    McConville, Jason T.
    Yang, Wei
    Williams, Robert O., III
    McGinity, James W.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (02) : 361 - 376
  • [37] Continuous Processing of Micropellets via Hot-Melt Extrusion
    Spoerk, Martin
    Koutsamanis, Ioannis
    Kottlan, Andreas
    Makert, Christian
    Piller, Michael
    Rajkovaca, Manuel
    Paudel, Amrit
    Khinast, Johannes
    AAPS PHARMSCITECH, 2022, 23 (07)
  • [38] PLASTICIZING EFFECT OF DRUG IN HOT-MELT EXTRUSION PROCESS
    Patera, J.
    Zaboj, M.
    Kuta, A.
    PROCEEDINGS OF THE 4TH INTERNATIONAL CONFERENCE ON CHEMICAL TECHNOLOGY, 1ST EDITION, 2016, : 517 - 522
  • [39] Preparation, characterization, and pharmacokinetics of tilmicosin taste-masked formulation via hot-melt extrusion technology
    Yan, Guoqing
    Liang, Qiuling
    Wen, Xuemei
    Peng, Jianbo
    Deng, Ruihan
    Lv, Li
    Ji, Min
    Deng, Xin
    Wu, Liqin
    Feng, Xin
    He, Jiakang
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2020, 196 (196)
  • [40] Dissolution Enhancement of Itraconazole by Hot-Melt Extrusion Alone and the Combination of Hot-Melt Extrusion and Rapid Freezing-Effect of Formulation and Processing Variables
    Lang, Bo
    McGinity, James W.
    Williams, Robert O., III
    MOLECULAR PHARMACEUTICS, 2014, 11 (01) : 186 - 196